Flexomics LLC
Waltham, MA
- UEI
- R7JKNCYTKYN1
- CAGE
- 8CHX8
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- SAM.gov registration date
- Physical address
- 764 Main St, Waltham, MA 02451, USA
- Website
- flexomics.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Enrich Biosystems Inc. | Branford, CT | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Aperture Bio, Inc. | Cambridge, MA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Lase Innovation Inc. | Waltham, MA | 334516 Analytical Laboratory Instrument Manufacturing |
| Cellchorus Inc. | Houston, TX | — |
| Sansimeon, Inc. | Wilmington, DE | — |
About the company
Flexomics LLC is a woman-owned small business and sole proprietorship registered to receive federal awards since June 2019. The company specializes in developing advanced cell analysis platforms that combine imaging and sequencing-based readouts for high-throughput single-cell phenotyping and genotyping. Flexomics' innovative technology aims to overcome limitations in current single-cell analysis methods by enabling the direct measurement and correlation of a cell's phenotype, physiological conditions, and molecular signatures. Their proprietary platform utilizes a high-density picowell array for single-cell isolation and fluorescent imaging, coupled with a unique nucleic-acid barcoding system.
The company has received multiple federal grant awards from the National Institutes of Health to support its research and development efforts. A notable project funded by the National Human Genome Research Institute (NHGRI) involves the development of a flexible platform for high-throughput single-cell phenotyping and genotyping. This $1,009,871 grant aims to create a system that can correlate live-cell responses and sequencing data for hundreds of thousands of individual cells in parallel, with applications in exploring cellular heterogeneity and understanding disease responses. Another significant project, funded by the National Cancer Institute (NCI), focuses on developing a novel approach for high-throughput identification and characterization of neoantigen-specific T-cell receptors to guide immunotherapy development. This research aims to address challenges in personalized cancer treatments by improving the identification of immunogenic neoantigen targets and their associated T-cell receptors, potentially expanding the pool of eligible patients for TCR T-cell therapies.
Quick answers
Is Flexomics LLC registered in SAM.gov?
Yes. Flexomics LLC's SAM.gov registration is active through September 24, 2027.
What is Flexomics LLC's most recent federal award?
Flexomics LLC's most recent federal grant award is A novel flexible approach for high-throughput single-cell phenotyping and genotyping (R44HG013448), from National Human Genome Research Institute (NIH), on February 9, 2024.
On GovTribe
See Flexomics LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors